


LimbuStem R&D Medical Products
Biotechnology Research • Ankara Caddesi İzmir/Bornova, Bornova, Türkiye • 1-10 Employees
Company overview
| Headquarters | Ankara Caddesi İzmir/Bornova, Bornova, Türkiye |
| Website | |
| NAICS | 541714 |
| Founded | 2020 |
| Employees | 1-10 |
Key Contact at LimbuStem R&D Medical Products
Mehmet Gürdal
Co-Founder & CTO
LimbuStem R&D Medical Products Email Formats
LimbuStem R&D Medical Products uses 1 email format. The most common is {first name}.{last name} (e.g., john.doe@limbustem.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@limbustem.com | 100% |
About LimbuStem R&D Medical Products
LimbuStem is a research and development (R&D), producing and delivering company in the field of advanced therapy medicinal products (ATMPs). LimbuStem is a techno-entrepreneurship (start-up) company supported by The Scientific and Technological Research Council of Turkey (TÜBİTAK). Headquartered in Izmir, Turkey. Today, LimbuStem focuses on developing, producing and marketing in vitro expanded corneal epithelial stem cells for patient-specific treatment of damaged cornea. Besides, LimbuStem's bioengineers focus on processing/preparing of human amniotic membrane for directly clinical use. LimbuStem produces/processes all advanced therapy products at full licensed/certified GMP laboratories in accordance with legal regulations.
LimbuStem R&D Medical Products revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
LimbuStem R&D Medical Products has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
LimbuStem R&D Medical Products has never raised funding before.
Frequently asked questions
4.8
40,000 users



